Mankind Pharma Ltd 543904
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- INR 2,247.45
- Day Range
- INR 2,180.30–2,282.85
- 52-Week Range
- INR 1,240.75–2,488.65
- Bid/Ask
- INR 0.00 / INR 0.00
- Market Cap
- INR 879.39 Bil
- Volume/Avg
- 11,754 / 27,080
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Mankind Pharma Ltd is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It operates at the intersection of Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices and has an established track record of building and scaling brands in-house. The company's brands include Manforce, Prega News and Gas-O-Fast.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Growth
- Total Number of Employees
- 18,468
- Website
- https://www.mankindpharma.com
Comparables
Valuation
|
Metric
|
543904
|
500672
|
531599
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 27.68 | 28.79 |
Price/Book Value | 10.68 | 3.69 | 3.78 |
Price/Sales | — | 8.10 | 3.93 |
Price/Cash Flow | — | 48.07 | 32.35 |
Price/Earnings
543904
500672
531599
Financial Strength
|
Metric
|
543904
|
500672
|
531599
|
|---|---|---|---|
Quick Ratio | 1.60 | 3.92 | 1.70 |
Current Ratio | 2.66 | 4.29 | 3.04 |
Interest Coverage | 32.14 | 44.14 | 95.60 |
Quick Ratio
543904
500672
531599
Profitability
|
Metric
|
543904
|
500672
|
531599
|
|---|---|---|---|
Return on Assets (Normalized) | 12.68% | — | — |
Return on Equity (Normalized) | 17.56% | — | — |
Return on Invested Capital (Normalized) | 16.41% | — | — |
Return on Assets
543904
500672
531599
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Qhwcndcgm | Bzmx | $77.1 Bil | |
MKKGY
| Merck KGaA ADR | Wpyknlmzry | Xtbcgc | $74.3 Bil | |
HLN
| Haleon PLC ADR | Tkvbdbjpk | Hzbj | $37.6 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Kvstbjzj | Fkm | $18.3 Bil | |
VTRS
| Viatris Inc | Dyzhdzn | Rbvl | $13.5 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Czbqpbttf | Cdjhk | $11.7 Bil | |
CTLT
| Catalent Inc | Llltbddbs | Crzsvkw | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Nbbwzpkcv | Rmvtd | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Vbmztzxg | Dgjb | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Hnnxgndj | Ywdpdnm | $3.5 Bil |